Exelixis Inc (EXEL) · Insider trading
What Exelixis's directors, officers and largest holders bought and sold themselves, from the Form 4 each of them files with the SEC within two business days of a trade. Open-market purchases and sales first: those are the trades somebody chose to make at the market price.
Bought, 12 months
$1.19M
1 insider, 1 trade
Sold, 12 months
$42.24M
12 insiders, 16% under a plan
Net, 12 months
−$41.06M
bought less sold
Latest filing
2026-08-12
filings read to 2026-10-19
Who traded, two years
| Insider | Bought | Sold | Trades | Last trade | Holds after |
|---|---|---|---|---|---|
| Haley Patrick J.EVP, Commercial | – | $19.72M | 16 | 2026-05-20 | 357,638 |
| Aftab DanaEVP, Research and Development | – | $12.18M | 8 | 2026-05-26 | 594,741 |
| Senner Christopher J.EVP and CFO | – | $10.22M | 5 | 2026-05-18 | 952,317 |
| Smith JulieDirector | – | $7.49M | 5 | 2026-02-18 | 20,590 |
| Papadopoulos SteliosDirector | – | $5.97M | 3 | 2025-11-12 | 1,189,228 |
| Hessekiel JeffreyEVP & General Counsel | – | $5.77M | 4 | 2025-05-15 | 693,396 |
| Poste GeorgeDirector | – | $5.26M | 4 | 2026-05-07 | 118,832 |
| Wyszomierski Jack LDirector | – | $5.24M | 4 | 2026-06-01 | 284,384 |
| Peterson Amy C.EVP Prod Dev & Med Aff & CMO | – | $3.31M | 1 | 2025-05-16 | 465,393 |
| Freire Maria CDirector | – | $2.49M | 2 | 2026-05-07 | 100,819 |
| Beckerle Mary CDirector | – | $2.36M | 6 | 2026-08-10 | 16,079 |
| Oliver BobDirector | – | $2.02M | 3 | 2026-02-13 | 42,282 |
| Eckhardt Sue GailDirector | – | $1.87M | 6 | 2026-06-01 | 16,079 |
| Caligan Partners LPDirector, Other | $1.19M | – | 1 | 2025-11-25 | – |
| Hefti BrendaSVP and General Counsel | – | $1.15M | 2 | 2026-05-18 | 106,762 |
| Heyman Tomas J.Director | – | $201,254 | 1 | 2025-05-21 | 32,470 |
Open-market purchases and sales
Newest first. “Plan” marks a trade made under a 10b5-1 plan set up in advance.
| Date | Insider | Trade | Shares | Price | Value | Holds after | Filing |
|---|---|---|---|---|---|---|---|
| 2026-08-10 | Beckerle Mary CDirector | Saleplan | 9,812 | 53.66 | $526,512 | 16,079 | Form 4 |
| 2026-06-01 | Eckhardt Sue GailDirector | Saleplan | 9,812 | 50.14 | $491,974 | 16,079 | Form 4 |
| 2026-06-01 | Wyszomierski Jack LDirector | Saleplan | 3,925 | 50.55 | $198,409 | 284,384 | Form 4 |
| 2026-05-26 | Aftab DanaEVP, Research and Development | Sale | 43,451 | 50.35 | $2.19M | 594,741 | Form 4 |
| 2026-05-20 | Haley Patrick J.EVP, Commercial | Sale | 32,110 | 49.81 | $1.60M | 357,638 | Form 4 |
| 2026-05-18 | Hefti BrendaSVP and General Counsel | Saleplan | 6,625 | 50.21 | $332,641 | 106,762 | Form 4 |
| 2026-05-18 | Senner Christopher J.EVP and CFO | Sale | 34,901 | 50.00 | $1.75M | 952,317 | Form 4 |
| 2026-05-07 | Poste GeorgeDirector | Sale | 60,000 | 45.71 | $2.74M | 118,832 | Form 4 |
| 2026-05-07 | Freire Maria CDirector | Sale | 20,634 | 46.00 | $949,164 | 100,819 | Form 4 |
| 2026-05-07 | Beckerle Mary CDirector | Sale | 7,712 | 48.45 | $373,646 | 17,524 | Form 4 |
| 2026-02-24 | Aftab DanaEVP, Research and Development | Sale | 47,918 | 44.50 | $2.13M | 616,106 | Form 4 |
| 2026-02-19 | Aftab DanaEVP, Research and Development | Sale | 29,873 | 44.35 | $1.32M | 664,024 | Form 4 |
| 2026-02-18 | Wyszomierski Jack LDirector | Saleplan | 99,574 | 44.01 | $4.38M | 279,942 | Form 4 |
| 2026-02-18 | Smith JulieDirector | Sale | 44,087 | 44.50 | $1.96M | 20,590 | Form 4 |
| 2026-02-18 | Smith JulieDirector | Sale | 20,030 | 44.30 | $887,329 | 20,590 | Form 4 |
| 2026-02-18 | Hefti BrendaSVP and General Counsel | Saleplan | 18,669 | 44.01 | $821,623 | 96,512 | Form 4 |
| 2026-02-17 | Smith JulieDirector | Sale | 42,422 | 43.33 | $1.84M | 20,590 | Form 4 |
| 2026-02-17 | Haley Patrick J.EVP, Commercial | Sale | 3,036 | 43.84 | $133,098 | 446,686 | Form 4 |
| 2026-02-17 | Haley Patrick J.EVP, Commercial | Sale | 64,778 | 43.50 | $2.82M | 381,908 | Form 4 |
| 2026-02-17 | Senner Christopher J.EVP and CFO | Sale | 30,617 | 43.67 | $1.34M | 976,092 | Form 4 |
| 2026-02-13 | Oliver BobDirector | Sale | 9,088 | 43.61 | $396,328 | 42,282 | Form 4 |
| 2026-02-13 | Oliver BobDirector | Sale | 21,162 | 43.90 | $929,012 | 21,120 | Form 4 |
| 2026-02-13 | Eckhardt Sue GailDirector | Saleplan | 3,856 | 43.79 | $168,854 | 17,524 | Form 4 |
| 2026-02-13 | Senner Christopher J.EVP and CFO | Sale | 34,278 | 43.00 | $1.47M | 1,042,579 | Form 4 |
| 2025-11-25 | Caligan Partners LPDirector, Otherwith Johnson David Edward | Buyindirect | 27,532 | 43.12 | $1.19M | 1,553,262 | Form 4 |
| 2025-11-21 | Haley Patrick J.EVP, Commercial | Sale | 28,043 | 42.58 | $1.19M | 374,029 | Form 4 |
| 2025-11-20 | Haley Patrick J.EVP, Commercial | Sale | 10,000 | 42.11 | $421,100 | 402,072 | Form 4 |
| 2025-11-20 | Haley Patrick J.EVP, Commercial | Saleindirect | 23,539 | 41.93 | $986,990 | 0 | Form 4 |
| 2025-11-20 | Haley Patrick J.EVP, Commercial | Saleindirect | 10,648 | 41.77 | $444,767 | 0 | Form 4 |
| 2025-11-12 | Papadopoulos SteliosDirector | Sale | 100,000 | 43.55 | $4.36M | 1,189,228 | Form 4 |
| 2025-11-11 | Beckerle Mary CDirector | Sale | 5,784 | 42.03 | $243,102 | 40,218 | Form 4 |
| 2025-11-11 | Beckerle Mary CDirector | Sale | 18,838 | 41.90 | $789,312 | 21,380 | Form 4 |
| 2025-11-11 | Aftab DanaEVP, Research and Development | Sale | 48,383 | 42.50 | $2.06M | 664,778 | Form 4 |
| 2025-06-03 | Wyszomierski Jack LDirector | Saleplan | 7,535 | 43.09 | $324,683 | 358,882 | Form 4 |
| 2025-06-02 | Eckhardt Sue GailDirector | Saleplan | 18,834 | 42.74 | $804,965 | 21,384 | Form 4 |
| 2025-06-02 | Eckhardt Sue GailDirector | Saleplan | 4 | 43.67 | $175 | 21,380 | Form 4 |
| 2025-05-21 | Heyman Tomas J.Director | Sale | 4,544 | 44.29 | $201,254 | 32,470 | Form 4 |
| 2025-05-20 | Haley Patrick J.EVP, Commercial | Sale | 34,387 | 44.06 | $1.52M | 412,072 | Form 4 |
| 2025-05-16 | Peterson Amy C.EVP Prod Dev & Med Aff & CMO | Sale | 72,776 | 45.47 | $3.31M | 465,393 | Form 4 |
| 2025-05-16 | Senner Christopher J.EVP and CFO | Sale | 100,000 | 46.00 | $4.60M | 967,842 | Form 4 |
31 more
| 2025-05-16 | Poste GeorgeDirector | Sale | 20,634 | 45.99 | $948,958 | 169,020 | Form 4 |
| 2025-05-15 | Haley Patrick J.EVP, Commercial | Saleplan | 10,000 | 46.95 | $469,500 | 446,459 | Form 4 |
| 2025-05-15 | Haley Patrick J.EVP, Commercial | Saleplan | 116,383 | 48.05 | $5.59M | 446,459 | Form 4 |
| 2025-05-15 | Hessekiel JeffreyEVP & General Counsel | Sale | 25,000 | 46.18 | $1.15M | 693,396 | Form 4 |
| 2025-05-15 | Papadopoulos SteliosDirector | Sale | 20,634 | 44.35 | $915,118 | 1,279,416 | Form 4 |
| 2025-05-15 | Papadopoulos SteliosDirector | Sale | 15,874 | 44.35 | $704,012 | 1,279,416 | Form 4 |
| 2025-05-14 | Haley Patrick J.EVP, Commercial | Saleplan | 10,000 | 42.68 | $426,800 | 491,164 | Form 4 |
| 2025-05-01 | Aftab DanaCSO/EVP Disc & Trans Research | Saleplan | 1,508 | 39.00 | $58,812 | 693,181 | Form 4 |
| 2025-03-03 | Haley Patrick J.EVP, Commercial | Saleplan | 10,000 | 38.80 | $388,000 | 341,028 | Form 4 |
| 2025-02-28 | Wyszomierski Jack LDirector | Saleplan | 8,768 | 37.80 | $331,430 | 356,605 | Form 4 |
| 2025-02-28 | Smith JulieDirector | Sale | 19,294 | 37.62 | $725,840 | 10,778 | Form 4 |
| 2025-02-27 | Smith JulieDirector | Sale | 54,514 | 38.13 | $2.08M | 10,778 | Form 4 |
| 2025-02-25 | Oliver BobDirector | Sale | 18,647 | 37.25 | $694,601 | 33,514 | Form 4 |
| 2025-02-24 | Senner Christopher J.EVP and CFO | Sale | 29,314 | 36.14 | $1.06M | 779,607 | Form 4 |
| 2025-02-24 | Aftab DanaCSO/EVP Disc & Trans Research | Sale | 26,987 | 36.75 | $991,772 | 511,908 | Form 4 |
| 2025-02-24 | Haley Patrick J.EVP, Commercial | Sale | 52,636 | 36.98 | $1.95M | 303,310 | Form 4 |
| 2025-02-14 | Eckhardt Sue GailDirector | Saleplan | 7,712 | 35.01 | $269,997 | 34,262 | Form 4 |
| 2025-02-14 | Eckhardt Sue GailDirector | Saleplan | 3,856 | 35.04 | $135,114 | 30,406 | Form 4 |
| 2025-02-14 | Freire Maria CDirector | Sale | 44,114 | 34.94 | $1.54M | 91,007 | Form 4 |
| 2025-02-14 | Poste GeorgeDirector | Sale | 15,874 | 34.74 | $551,463 | 169,020 | Form 4 |
| 2025-02-14 | Beckerle Mary CDirector | Sale | 8,354 | 34.87 | $291,304 | 34,262 | Form 4 |
| 2025-02-14 | Beckerle Mary CDirector | Sale | 3,856 | 34.90 | $134,574 | 30,406 | Form 4 |
| 2024-11-29 | Hessekiel JeffreyEVP & General Counsel | Sale | 60,000 | 36.67 | $2.20M | 486,059 | Form 4 |
| 2024-11-22 | Haley Patrick J.EVP, Commercial | Saleplan | 10,000 | 35.27 | $352,700 | 278,665 | Form 4 |
| 2024-11-18 | Haley Patrick J.EVP, Commercial | Saleplan | 22,207 | 34.31 | $761,922 | 308,046 | Form 4 |
| 2024-11-18 | Haley Patrick J.EVP, Commercial | Saleplan | 19,381 | 34.41 | $666,900 | 288,665 | Form 4 |
| 2024-11-05 | Aftab DanaCSO/EVP Disc & Trans Research | Saleplan | 96,986 | 35.00 | $3.39M | 498,945 | Form 4 |
| 2024-11-01 | Poste GeorgeDirector | Sale | 30,000 | 34.00 | $1.02M | 169,020 | Form 4 |
| 2024-11-01 | Hessekiel JeffreyEVP & General Counsel | Saleplan | 50,000 | 34.13 | $1.71M | 530,325 | Form 4 |
| 2024-10-30 | Aftab DanaCSO/EVP Disc & Trans Research | Saleplan | 1,162 | 31.40 | $36,487 | 498,945 | Form 4 |
| 2024-10-28 | Hessekiel JeffreyEVP & General Counsel | Saleplan | 25,000 | 28.39 | $709,750 | 580,325 | Form 4 |
Grants, exercises and other transactions
Pay, tax and paperwork rather than a choice to trade at the market price. Two years.
46 × grant or award41 × shares withheld for tax29 × option exercise22 × gift
Show them
| Date | Insider | What | Shares | Price | Holds after | Filing |
|---|---|---|---|---|---|---|
| 2026-05-27 | Poste GeorgeDirector | Grant or award A | +8,367 | – | 127,199 | Form 4 |
| 2026-05-27 | Wyszomierski Jack LDirector | Grant or award A | +8,367 | – | 288,309 | Form 4 |
| 2026-05-27 | Oliver BobDirector | Grant or award A | +8,367 | – | 29,487 | Form 4 |
| 2026-05-27 | Beckerle Mary CDirector | Grant or award A | +8,367 | – | 25,891 | Form 4 |
| 2026-05-27 | Freire Maria CDirector | Grant or award A | +8,367 | – | 109,186 | Form 4 |
| 2026-05-27 | Smith JulieDirector | Grant or award A | +8,367 | – | 28,957 | Form 4 |
| 2026-05-27 | Eckhardt Sue GailDirector | Grant or award A | +8,367 | – | 25,891 | Form 4 |
| 2026-05-27 | Heyman Tomas J.Director | Grant or award A | +8,367 | – | 50,649 | Form 4 |
| 2026-05-27 | Papadopoulos SteliosDirector | Grant or award A | +8,367 | – | 1,197,595 | Form 4 |
| 2026-05-18 | Morrissey MichaelDirector, President and CEO | Gift G | −124,047 | – | 1,362,008 | Form 4 |
| 2026-05-18 | Morrissey MichaelDirector, President and CEO | Gift G | +124,047 | – | 2,004,327 | Form 4 |
| 2026-05-15 | Aftab DanaEVP, Research and Development | Shares withheld for tax F | −30,578 | 51.10 | 638,192 | Form 4 |
| 2026-05-15 | Hefti BrendaSVP and General Counsel | Shares withheld for tax F | −6,411 | 51.10 | 113,387 | Form 4 |
| 2026-05-15 | Haley Patrick J.EVP, Commercial | Shares withheld for tax F | −33,265 | 51.10 | 389,748 | Form 4 |
| 2026-05-15 | Senner Christopher J.EVP and CFO | Shares withheld for tax F | −40,892 | 51.10 | 987,218 | Form 4 |
| 2026-05-15 | Morrissey MichaelDirector, President and CEO | Shares withheld for tax F | −128,497 | 51.10 | 1,486,055 | Form 4 |
| 2026-05-07 | Freire Maria CDirector | Option exercise M | +20,634 | 19.77 | 121,453 | Form 4 |
| 2026-05-07 | Beckerle Mary CDirector | Option exercise M | +3,856 | 23.24 | 25,236 | Form 4 |
| 2026-05-06 | Morrissey MichaelDirector, President and CEO | Gift G | −109,676 | – | 1,880,280 | Form 4 |
| 2026-02-26 | Morrissey MichaelDirector, President and CEO | Grant or award A | +160,437 | – | 1,614,552 | Form 4 |
| 2026-02-26 | Haley Patrick J.EVP, Commercial | Grant or award A | +40,459 | – | 422,367 | Form 4 |
| 2026-02-26 | Hefti BrendaSVP and General Counsel | Grant or award A | +23,119 | – | 119,631 | Form 4 |
| 2026-02-26 | Senner Christopher J.EVP and CFO | Grant or award A | +52,018 | – | 1,028,110 | Form 4 |
| 2026-02-26 | Aftab DanaEVP, Research and Development | Grant or award A | +52,018 | – | 668,124 | Form 4 |
| 2026-02-24 | Morrissey MichaelDirector, President and CEO | Gift G | −100,278 | – | 1,989,956 | Form 4 |
| 2026-02-18 | Wyszomierski Jack LDirector | Option exercise M | +20,634 | 19.77 | 379,516 | Form 4 |
| 2026-02-18 | Smith JulieDirector | Option exercise M | +44,087 | 19.39 | 64,677 | Form 4 |
| 2026-02-18 | Smith JulieDirector | Option exercise M | +20,030 | 21.69 | 40,620 | Form 4 |
| 2026-02-18 | Morrissey MichaelDirector, President and CEO | Gift G | −125,094 | – | 1,454,115 | Form 4 |
| 2026-02-18 | Morrissey MichaelDirector, President and CEO | Gift G | +125,094 | – | 2,090,234 | Form 4 |
| 2026-02-17 | Smith JulieDirector | Option exercise M | +42,422 | 18.19 | 63,012 | Form 4 |
| 2026-02-17 | Morrissey MichaelDirector, President and CEO | Gift G | −250,736 | – | 1,579,209 | Form 4 |
| 2026-02-17 | Morrissey MichaelDirector, President and CEO | Gift G | +250,736 | – | 1,965,140 | Form 4 |
| 2026-02-15 | Hefti BrendaSVP and General Counsel | Shares withheld for tax F | −5,430 | 43.92 | 115,181 | Form 4 |
| 2026-02-15 | Aftab DanaEVP, Research and Development | Shares withheld for tax F | −26,485 | 43.92 | 706,617 | Form 4 |
| 2026-02-15 | Aftab DanaEVP, Research and Development | Shares withheld for tax F | −12,720 | 43.92 | 693,897 | Form 4 |
| 2026-02-15 | Morrissey MichaelDirector, President and CEO | Shares withheld for tax F | −120,390 | 43.92 | 1,829,945 | Form 4 |
| 2026-02-15 | Haley Patrick J.EVP, Commercial | Shares withheld for tax F | −31,483 | 43.92 | 449,722 | Form 4 |
| 2026-02-15 | Senner Christopher J.EVP and CFO | Shares withheld for tax F | −35,870 | 43.92 | 1,006,709 | Form 4 |
| 2026-02-13 | Oliver BobDirector | Option exercise M | +9,088 | 19.28 | 51,370 | Form 4 |
| 2026-02-13 | Morrissey MichaelDirector, President and CEO | Option exercise M | +494,700 | 21.31 | 2,319,941 | Form 4 |
| 2026-02-13 | Morrissey MichaelDirector, President and CEO | Shares withheld for tax F | −369,606 | 43.92 | 1,950,335 | Form 4 |
| 2026-01-15 | Senner Christopher J.EVP and CFO | Grant or award A | +149,474 | – | 1,117,316 | Form 4 |
| 2026-01-15 | Senner Christopher J.EVP and CFO | Shares withheld for tax F | −40,459 | 45.23 | 1,076,857 | Form 4 |
| 2026-01-15 | Haley Patrick J.EVP, Commercial | Grant or award A | +139,508 | – | 513,537 | Form 4 |
| 2026-01-15 | Haley Patrick J.EVP, Commercial | Shares withheld for tax F | −32,332 | 45.23 | 481,205 | Form 4 |
| 2026-01-15 | Aftab DanaEVP, Research and Development | Grant or award A | +119,578 | – | 760,356 | Form 4 |
| 2026-01-15 | Aftab DanaEVP, Research and Development | Shares withheld for tax F | −27,254 | 45.23 | 733,102 | Form 4 |
| 2026-01-15 | Morrissey MichaelDirector, President and CEO | Grant or award A | +548,073 | – | 1,964,765 | Form 4 |
| 2026-01-15 | Morrissey MichaelDirector, President and CEO | Shares withheld for tax F | −139,524 | 45.23 | 1,825,241 | Form 4 |
| 2025-12-03 | Hefti BrendaSVP and General Counsel | Grant or award A | +30,170 | – | 120,611 | Form 4 |
| 2025-11-21 | Aftab DanaEVP, Research and Development | Gift G | −24,000 | – | 640,778 | Form 4 |
| 2025-11-17 | Oliver BobDirector | Gift G | −1,044 | – | 42,282 | Form 4 |
| 2025-11-12 | Morrissey MichaelDirector, President and CEO | Gift G | −101,548 | – | 1,416,692 | Form 4 |
| 2025-11-12 | Morrissey MichaelDirector, President and CEO | Gift G | +101,548 | – | 1,794,404 | Form 4 |
| 2025-11-12 | Morrissey MichaelDirector, President and CEO | Gift G | −80,000 | – | 1,714,404 | Form 4 |
| 2025-11-11 | Beckerle Mary CDirector | Option exercise M | +5,784 | 23.24 | 46,002 | Form 4 |
| 2025-11-11 | Morrissey MichaelDirector, President and CEO | Gift G | −160,000 | – | 1,692,856 | Form 4 |
| 2025-10-08 | Aftab DanaEVP, Research & Development | Grant or award A | +50,673 | – | 713,161 | Form 4 |
| 2025-05-29 | Smith JulieDirector | Grant or award A | +9,812 | – | 20,590 | Form 4 |
| 2025-05-29 | Eckhardt Sue GailDirector | Grant or award A | +9,812 | – | 40,218 | Form 4 |
| 2025-05-29 | Papadopoulos SteliosDirector | Grant or award A | +9,812 | – | 1,289,228 | Form 4 |
| 2025-05-29 | Freire Maria CDirector | Grant or award A | +9,812 | – | 100,819 | Form 4 |
| 2025-05-29 | Wyszomierski Jack LDirector | Grant or award A | +9,812 | – | 366,417 | Form 4 |
| 2025-05-29 | Poste GeorgeDirector | Grant or award A | +9,812 | – | 178,832 | Form 4 |
| 2025-05-29 | Heyman Tomas J.Director | Grant or award A | +9,812 | – | 42,282 | Form 4 |
| 2025-05-29 | Oliver BobDirector | Grant or award A | +9,812 | – | 43,326 | Form 4 |
| 2025-05-29 | Beckerle Mary CDirector | Grant or award A | +9,812 | – | 40,218 | Form 4 |
| 2025-05-16 | Peterson Amy C.EVP Prod Dev & Med Aff & CMO | Option exercise M | +40,000 | 21.75 | 538,169 | Form 4 |
| 2025-05-16 | Morrissey MichaelDirector, President and CEO | Gift G | −87,871 | – | 1,518,240 | Form 4 |
| 2025-05-16 | Morrissey MichaelDirector, President and CEO | Gift G | +87,871 | – | 1,852,856 | Form 4 |
| 2025-05-16 | Senner Christopher J.EVP and CFO | Option exercise M | +100,000 | 18.80 | 1,067,842 | Form 4 |
| 2025-05-16 | Poste GeorgeDirector | Option exercise M | +20,634 | 19.77 | 189,654 | Form 4 |
| 2025-05-15 | Peterson Amy C.EVP Prod Dev & Med Aff & CMO | Shares withheld for tax F | −8,303 | 44.65 | 498,169 | Form 4 |
| 2025-05-15 | Haley Patrick J.EVP, Commercial | Shares withheld for tax F | −34,705 | 44.65 | 456,459 | Form 4 |
| 2025-05-15 | Haley Patrick J.EVP, Commercial | Option exercise M | +116,383 | 18.80 | 562,842 | Form 4 |
| 2025-05-15 | Hessekiel JeffreyEVP & General Counsel | Shares withheld for tax F | −34,035 | 44.65 | 718,396 | Form 4 |
| 2025-05-15 | Morrissey MichaelDirector, President and CEO | Shares withheld for tax F | −104,769 | 44.65 | 1,606,111 | Form 4 |
| 2025-05-15 | Papadopoulos SteliosDirector | Option exercise M | +20,634 | 19.77 | 1,300,050 | Form 4 |
| 2025-05-15 | Papadopoulos SteliosDirector | Option exercise M | +15,874 | 20.50 | 1,295,290 | Form 4 |
| 2025-05-15 | Senner Christopher J.EVP and CFO | Shares withheld for tax F | −41,422 | 44.65 | 967,842 | Form 4 |
| 2025-05-15 | Aftab DanaCSO/EVP Disc & Trans Research | Shares withheld for tax F | −30,693 | 44.65 | 662,488 | Form 4 |
| 2025-05-14 | Morrissey MichaelDirector, President and CEO | Option exercise M | +308,365 | 18.80 | 1,931,374 | Form 4 |
| 2025-05-14 | Morrissey MichaelDirector, President and CEO | Shares withheld for tax F | −220,494 | 44.65 | 1,710,880 | Form 4 |
| 2025-03-31 | Senner Christopher J.EVP and CFO | Grant or award A | +170,009 | – | 1,009,264 | Form 4 |
| 2025-03-31 | Haley Patrick J.EVP, Commercial | Grant or award A | +159,383 | – | 500,411 | Form 4 |
| 2025-03-31 | Hessekiel JeffreyEVP & General Counsel | Grant or award A | +154,070 | – | 751,678 | Form 4 |
| 2025-03-31 | Aftab DanaCSO/EVP Disc & Trans Research | Grant or award A | +132,819 | – | 693,936 | Form 4 |
| 2025-03-31 | Morrissey MichaelDirector, President and CEO | Grant or award A | +589,719 | – | 1,623,009 | Form 4 |
| 2025-03-31 | Peterson Amy C.EVP Prod Dev & Med Aff & CMO | Grant or award A | +159,383 | – | 506,472 | Form 4 |
| 2025-02-28 | Wyszomierski Jack LDirector | Option exercise M | +15,874 | 20.50 | 365,373 | Form 4 |
| 2025-02-28 | Smith JulieDirector | Option exercise M | +19,294 | 19.77 | 30,072 | Form 4 |
| 2025-02-27 | Smith JulieDirector | Option exercise M | +31,167 | 20.50 | 41,945 | Form 4 |
| 2025-02-27 | Smith JulieDirector | Option exercise M | +23,347 | 19.77 | 65,292 | Form 4 |
| 2025-02-26 | Senner Christopher J.EVP and CFO | Grant or award A | +59,648 | – | 839,255 | Form 4 |
| 2025-02-26 | Peterson Amy C.EVP Prod Dev & Med Aff & CMO | Grant or award A | +52,192 | – | 347,089 | Form 4 |
| 2025-02-26 | Hessekiel JeffreyEVP & General Counsel | Grant or award A | +52,192 | – | 597,608 | Form 4 |
| 2025-02-26 | Haley Patrick J.EVP, Commercial | Grant or award A | +47,718 | – | 351,028 | Form 4 |
| 2025-02-26 | Aftab DanaCSO/EVP Disc & Trans Research | Grant or award A | +49,209 | – | 561,117 | Form 4 |
| 2025-02-26 | Morrissey MichaelDirector, President and CEO | Grant or award A | +184,909 | – | 1,033,290 | Form 4 |
| 2025-02-25 | Oliver BobDirector | Option exercise M | +15,147 | 19.28 | 52,161 | Form 4 |
| 2025-02-24 | Senner Christopher J.EVP and CFO | Option exercise M | +29,314 | 18.80 | 808,921 | Form 4 |
| 2025-02-24 | Morrissey MichaelDirector, President and CEO | Gift G | −177,985 | – | 848,381 | Form 4 |
| 2025-02-24 | Morrissey MichaelDirector, President and CEO | Gift G | +177,985 | – | 1,764,985 | Form 4 |
| 2025-02-15 | Morrissey MichaelDirector, President and CEO | Shares withheld for tax F | −63,570 | 35.00 | 1,026,366 | Form 4 |
| 2025-02-15 | Aftab DanaCSO/EVP Disc & Trans Research | Shares withheld for tax F | −16,053 | 35.00 | 551,590 | Form 4 |
| 2025-02-15 | Aftab DanaCSO/EVP Disc & Trans Research | Shares withheld for tax F | −12,695 | 35.00 | 538,895 | Form 4 |
| 2025-02-15 | Haley Patrick J.EVP, Commercial | Shares withheld for tax F | −18,906 | 35.00 | 355,946 | Form 4 |
| 2025-02-15 | Hessekiel JeffreyEVP & General Counsel | Shares withheld for tax F | −18,134 | 35.00 | 545,416 | Form 4 |
| 2025-02-15 | Senner Christopher J.EVP and CFO | Shares withheld for tax F | −21,591 | 35.00 | 779,607 | Form 4 |
| 2025-02-14 | Eckhardt Sue GailDirector | Option exercise M | +7,712 | 23.24 | 41,974 | Form 4 |
| 2025-02-14 | Freire Maria CDirector | Option exercise M | +15,874 | 20.50 | 106,881 | Form 4 |
| 2025-02-14 | Freire Maria CDirector | Option exercise M | +28,240 | 22.10 | 135,121 | Form 4 |
| 2025-02-14 | Poste GeorgeDirector | Option exercise M | +15,874 | 20.50 | 184,894 | Form 4 |
| 2025-02-14 | Beckerle Mary CDirector | Option exercise M | +8,354 | 23.24 | 42,616 | Form 4 |
| 2025-01-16 | Haley Patrick J.EVP, Commercial | Grant or award A | +123,750 | – | 402,415 | Form 4 |
| 2025-01-16 | Haley Patrick J.EVP, Commercial | Shares withheld for tax F | −27,563 | 37.27 | 374,852 | Form 4 |
| 2025-01-16 | Aftab DanaCSO/EVP Disc & Trans Research | Grant or award A | +104,106 | – | 590,213 | Form 4 |
| 2025-01-16 | Aftab DanaCSO/EVP Disc & Trans Research | Shares withheld for tax F | −22,570 | 37.27 | 567,643 | Form 4 |
| 2025-01-16 | Hessekiel JeffreyEVP & General Counsel | Grant or award A | +118,780 | – | 589,839 | Form 4 |
| 2025-01-16 | Hessekiel JeffreyEVP & General Counsel | Shares withheld for tax F | −26,289 | 37.27 | 563,550 | Form 4 |
| 2025-01-16 | Senner Christopher J.EVP and CFO | Grant or award A | +132,973 | – | 837,147 | Form 4 |
| 2025-01-16 | Senner Christopher J.EVP and CFO | Shares withheld for tax F | −35,949 | 37.27 | 801,198 | Form 4 |
| 2025-01-16 | Morrissey MichaelDirector, President and CEO | Grant or award A | +473,226 | – | 1,210,180 | Form 4 |
| 2025-01-16 | Morrissey MichaelDirector, President and CEO | Shares withheld for tax F | −120,244 | 37.27 | 1,089,936 | Form 4 |
| 2024-12-20 | Morrissey MichaelDirector, President and CEO | Gift G | −179,788 | – | 736,954 | Form 4 |
| 2024-12-20 | Morrissey MichaelDirector, President and CEO | Gift G | +179,788 | – | 1,587,000 | Form 4 |
| 2024-11-29 | Hessekiel JeffreyEVP & General Counsel | Gift G | −15,000 | – | 471,059 | Form 4 |
| 2024-11-27 | Hessekiel JeffreyEVP & General Counsel | Option exercise M | +129,314 | 18.80 | 644,967 | Form 4 |
| 2024-11-27 | Hessekiel JeffreyEVP & General Counsel | Shares withheld for tax F | −98,908 | 35.93 | 546,059 | Form 4 |
| 2024-11-15 | Peterson Amy C.EVP Prod Dev & Med Aff & CMO | Shares withheld for tax F | −27,224 | 35.05 | 294,897 | Form 4 |
| 2024-11-15 | Aftab DanaCSO/EVP Disc & Trans Research | Shares withheld for tax F | −12,838 | 35.05 | 486,107 | Form 4 |
| 2024-11-15 | Hessekiel JeffreyEVP & General Counsel | Shares withheld for tax F | −14,672 | 35.05 | 515,653 | Form 4 |
| 2024-11-15 | Haley Patrick J.EVP, Commercial | Shares withheld for tax F | −14,672 | 35.05 | 330,253 | Form 4 |
| 2024-11-15 | Morrissey MichaelDirector, President and CEO | Shares withheld for tax F | −47,642 | 35.05 | 916,742 | Form 4 |
| 2024-11-15 | Senner Christopher J.EVP and CFO | Shares withheld for tax F | −17,506 | 35.05 | 704,174 | Form 4 |
| 2024-11-05 | Aftab DanaCSO/EVP Disc & Trans Research | Option exercise M | +96,986 | 18.80 | 595,931 | Form 4 |
| 2024-10-31 | Morrissey MichaelDirector, President and CEO | Gift G | −46,000 | – | 1,407,212 | Form 4 |
How to read it
- Buy, sale
- Code P and S on the form: shares bought or sold in the market, at the market price. The other codes are mostly pay (a grant, an option exercised) or tax (shares the company withheld), and say little about what the insider thinks of the price.
- Plan
- A sale or purchase under a Rule 10b5-1 plan, set up in advance and running on its own schedule. Since April 2023 the form has a box for it. Much executive selling is planned and says more about diversifying than about the company.
- Holds after
- The shares the insider still held after the trade, in the form the trade was in (directly, or indirectly through a trust or a fund).
- Value
- Shares times the price the form reports, which is often an average over several fills on the day.
Read from the SEC's own quarterly data sets of Forms 3, 4 and 5, and from each day's filings since the last one. A correcting amendment replaces the lines it restates. Every row links to its filing. None of this is advice: insiders sell for many reasons, and buy for fewer.